A potential drug successfully treats the severe form of nonalcoholic fatty liver disease in non-human primates bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests. Nonalcoholic steatohepatitis (NASH) causes scarring and inflammation in the liver and is estimated to affect up to 6.5% of the global population.
A protein degrader shows potential in targeting STAT5, a protein involved in leukemia and other forms of cancer. For decades, researchers have been interested in targeting the protein STAT5 in the fight against cancer. However, despite extensive efforts, STAT5 was eventually considered "undruggable
Brazil is an ideal country in which to examine the health effects of climate change, and a new Brazilian study finds that females and children 0-4 years are among the most affected.
《類股》防疫有望鬆綁＋五倍券 觀光股振奮 - 財經 chinatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chinatimes.com Daily Mail and Mail on Sunday newspapers.
脚踩三道红线 富力地产艰难求生_公司_地产频道首页_财经网 - CAIJING COM CN caijing.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from caijing.com.cn Daily Mail and Mail on Sunday newspapers.